Spire Eye Centre at Little Aston Hospital is celebrating its fifth anniversary by investing over a quarter of a million pounds in new technology and expanding its consulting team.
The investment is being made by both the Eye Centre in Sutton Coldfield and our sister centre at Spire South Bank Hospital in Worcester.
Collectively, Spire Eye Centre has acquired two pieces of equipment that will allow us to offer new services to patients, bringing the latest technologies and medical procedures to the region. This has been supported by two new consultants joining the specialist team bringing the total number to 10.
The total investment of £250,000 sees the hospitals acquire the latest diagnostic equipment, as well as the facilities to be able to perform laser refractive eye surgery and clear lens surgery – procedures that reduce the need for glasses.
The rise in demand for specialist eye services has resulted in the hospital expanding its capability and team of consultants. Joining the specialist eye team is Dan Calladine who is a corneal specialist and performs laser refractive eye surgery. Dan will work from both centres alongside consultant ophthalmic surgeon Monique Hope Ross who carries out clear lens surgery, which effectively replaces the natural lens of the eye with an artificial one.
Aidan Murray also joins the Spire Little Aston Hospital team as a consultant ophthalmic surgeon focusing upon the cosmetic treatment of eyelid disease as well as the treatment of thyroid eye disease and watery eye.
Monique Hope-Ross, consultant ophthalmic surgeon from Spire Eye Centre at Little Aston Hospital, who was involved in establishing the centre in 2009, said: “Advancements in the treatment of eye disease has grown exponentially over the past decade and we are now able to treat many more conditions and preserve sight for a growing number of patients.
“To do this, we need to continually invest in both medical technology and consultant expertise. The new scanners and laser equipment will enable patients at Spire Eye Centre to benefit from leading technology in both the diagnostic process and treatment.”